Delayed
NSE India S.E.
07:40:30 2024-07-16 am EDT
|
5-day change
|
1st Jan Change
|
587
INR
|
+0.51%
|
|
-0.52%
|
+15.41%
|
Fiscal Period: Maart |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
71,653
|
57,333
|
93,490
|
-
|
-
|
Enterprise Value (EV)
1 |
71,653
|
57,333
|
72,107
|
93,490
|
93,490
|
P/E ratio
|
15
x
|
18.6
x
|
39.2
x
|
32.9
x
|
24.3
x
|
Yield
|
-
|
1.39%
|
1.1%
|
0.66%
|
0.7%
|
Capitalization / Revenue
|
1.45
x
|
1.2
x
|
1.74
x
|
2.04
x
|
1.76
x
|
EV / Revenue
|
1.45
x
|
1.2
x
|
1.74
x
|
2.04
x
|
1.76
x
|
EV / EBITDA
|
8.61
x
|
10.5
x
|
17.1
x
|
16.1
x
|
12.6
x
|
EV / FCF
|
32.2
x
|
-303
x
|
-52.1
x
|
-62.5
x
|
-42.6
x
|
FCF Yield
|
3.11%
|
-0.33%
|
-1.92%
|
-1.6%
|
-2.35%
|
Price to Book
|
-
|
2.15
x
|
2.61
x
|
3.17
x
|
2.86
x
|
Nbr of stocks (in thousands)
|
159,281
|
159,281
|
159,281
|
-
|
-
|
Reference price
2 |
449.8
|
360.0
|
587.0
|
587.0
|
587.0
|
Announcement Date
|
5/17/22
|
5/16/23
|
5/14/24
|
-
|
-
|
Fiscal Period: März |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
49,494
|
47,727
|
41,358
|
45,864
|
53,115
|
EBITDA
1 |
-
|
8,318
|
5,471
|
4,211
|
5,813
|
7,415
|
EBIT
1 |
-
|
7,084
|
4,249
|
2,850
|
4,089
|
5,609
|
Operating Margin
|
-
|
14.31%
|
8.9%
|
6.89%
|
8.92%
|
10.56%
|
Earnings before Tax (EBT)
1 |
-
|
7,089
|
4,368
|
2,676
|
4,370
|
6,087
|
Net income
1 |
543.6
|
4,767
|
3,075
|
1,829
|
2,838
|
3,841
|
Net margin
|
-
|
9.63%
|
6.44%
|
4.42%
|
6.19%
|
7.23%
|
EPS
2 |
-
|
29.97
|
19.33
|
11.55
|
17.87
|
24.17
|
Free Cash Flow
1 |
-
|
2,226
|
-189.3
|
-1,384
|
-1,496
|
-2,196
|
FCF margin
|
-
|
4.5%
|
-0.4%
|
-3.35%
|
-3.26%
|
-4.13%
|
FCF Conversion (EBITDA)
|
-
|
26.76%
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
46.69%
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
5.000
|
5.000
|
3.850
|
4.100
|
Announcement Date
|
6/7/21
|
5/17/22
|
5/16/23
|
5/14/24
|
-
|
-
|
Fiscal Period: March |
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
-
|
12,865
|
12,958
|
11,658
|
13,036
|
11,583
|
11,450
|
10,750
|
10,716
|
9,395
|
10,354
|
10,480
|
EBITDA
1 |
-
|
2,220
|
1,424
|
1,409
|
1,529
|
1,513
|
1,021
|
1,166
|
1,055
|
996.7
|
991.8
|
1,137
|
EBIT
1 |
-
|
-
|
-
|
1,095
|
-
|
-
|
-
|
843.5
|
-
|
647
|
676.6
|
783
|
Operating Margin
|
-
|
-
|
-
|
9.39%
|
-
|
-
|
-
|
7.85%
|
-
|
6.89%
|
6.53%
|
7.47%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
1,216
|
755.1
|
-
|
707
|
651
|
601
|
719
|
Net income
1 |
0.0111
|
-
|
-
|
-
|
-
|
915.3
|
523.1
|
575.9
|
706
|
446.7
|
474.6
|
491
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
7.9%
|
4.57%
|
5.36%
|
6.59%
|
4.75%
|
4.58%
|
4.69%
|
EPS
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
3.630
|
-
|
2.800
|
2.900
|
3.400
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
10/19/21
|
2/1/22
|
5/17/22
|
8/5/22
|
10/20/22
|
1/31/23
|
5/16/23
|
7/26/23
|
-
|
-
|
-
|
-
|
Fiscal Period: March |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
2,226
|
-189
|
-1,384
|
-1,496
|
-2,196
|
ROE (net income / shareholders' equity)
|
-
|
21.9%
|
12.1%
|
6.77%
|
10.2%
|
12.7%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
7.63%
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
40,280
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
-
|
168.0
|
173.0
|
185.0
|
205.0
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
2,301
|
4,814
|
5,684
|
6,000
|
6,000
|
Capex / Sales
|
-
|
4.65%
|
10.09%
|
13.74%
|
13.08%
|
11.3%
|
Announcement Date
|
6/7/21
|
5/17/22
|
5/16/23
|
5/14/24
|
-
|
-
|
Average target price
559
INR Spread / Average Target -4.76% Consensus |
1st Jan change
|
Capi.
|
---|
| +15.41% | 1.11B | | +23.61% | 69.07B | | -3.98% | 46.81B | | +23.25% | 44.24B | | +35.43% | 29.06B | | +6.31% | 18.51B | | +13.16% | 17.34B | | -5.06% | 15.6B | | -28.83% | 15.04B | | -29.23% | 11.91B |
Other Specialty Chemicals
|